Does Aripiprazole Increase Compulsive Urges to Use Substances? Case Reports and Literature Review.

IF 2.9 3区 医学 Q2 PHARMACOLOGY & PHARMACY
Kamini Vasudev, Megha Kodancha
{"title":"Does Aripiprazole Increase Compulsive Urges to Use Substances? Case Reports and Literature Review.","authors":"Kamini Vasudev, Megha Kodancha","doi":"10.1097/JCP.0000000000002005","DOIUrl":null,"url":null,"abstract":"<p><strong>Purpose/background: </strong>Aripiprazole is commonly used to treat schizophrenia, bipolar disorder, and major depressive disorder and is preferred because of its relatively favorable side-effect profile. In 2016, the Food and Drug Administration released a warning regarding the risk of new impulse control problems with aripiprazole, including urges to gamble, binge eat, shop, and engage in sexual intercourse. These problems are rare but may cause significant harm if not recognized in time.</p><p><strong>Methods: </strong>This report presents 2 clinical cases to hypothesize that aripiprazole may increase urges and compulsive use of substances in some patients with a history of substance use disorders.</p><p><strong>Results: </strong>Both individuals had a previous history of substance use disorder before starting aripiprazole; they felt unable to stop using, as if compelled to use the substances while on aripiprazole, despite having good motivation to change. They reported a decreased urge to use substances after discontinuation of aripiprazole and were able to abstain from substances for sustained periods.</p><p><strong>Implications/conclusions: </strong>These case reports suggest that aripiprazole may increase urges and compulsive substance use in patients with a history of substance use disorders. The findings emphasize the importance of a thorough preprescription assessment, education, informed consent, and regular monitoring of patients prescribed aripiprazole for increased urges or compulsions to use substances, in addition to other impulsive-compulsive behaviors. Further research is needed to confirm the association.</p>","PeriodicalId":15455,"journal":{"name":"Journal of Clinical Psychopharmacology","volume":" ","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-04-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Psychopharmacology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1097/JCP.0000000000002005","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose/background: Aripiprazole is commonly used to treat schizophrenia, bipolar disorder, and major depressive disorder and is preferred because of its relatively favorable side-effect profile. In 2016, the Food and Drug Administration released a warning regarding the risk of new impulse control problems with aripiprazole, including urges to gamble, binge eat, shop, and engage in sexual intercourse. These problems are rare but may cause significant harm if not recognized in time.

Methods: This report presents 2 clinical cases to hypothesize that aripiprazole may increase urges and compulsive use of substances in some patients with a history of substance use disorders.

Results: Both individuals had a previous history of substance use disorder before starting aripiprazole; they felt unable to stop using, as if compelled to use the substances while on aripiprazole, despite having good motivation to change. They reported a decreased urge to use substances after discontinuation of aripiprazole and were able to abstain from substances for sustained periods.

Implications/conclusions: These case reports suggest that aripiprazole may increase urges and compulsive substance use in patients with a history of substance use disorders. The findings emphasize the importance of a thorough preprescription assessment, education, informed consent, and regular monitoring of patients prescribed aripiprazole for increased urges or compulsions to use substances, in addition to other impulsive-compulsive behaviors. Further research is needed to confirm the association.

阿立哌唑会增加使用药物的强迫冲动吗?病例报告和文献综述。
目的/背景:阿立哌唑通常用于治疗精神分裂症、双相情感障碍和重度抑郁症,由于其相对有利的副作用而被首选。2016年,美国食品和药物管理局发布了一项警告,称阿立哌唑有可能出现新的冲动控制问题,包括赌博、暴饮暴食、购物和性交的冲动。这些问题很少见,但如果不及时发现,可能会造成严重的危害。方法:本文报告2例临床病例,推测阿立哌唑可能会增加一些有物质使用障碍史的患者对物质的冲动和强迫性使用。结果:两个人在开始使用阿立哌唑之前都有药物使用障碍史;他们觉得无法停止使用,就好像在服用阿立哌唑时被迫使用这些物质,尽管他们有很好的动机去改变。他们报告说,停用阿立哌唑后,使用药物的冲动减少了,并且能够持续一段时间不使用药物。意义/结论:这些病例报告表明,阿立哌唑可能会增加有物质使用障碍史的患者的冲动和强迫性物质使用。研究结果强调了全面的处方前评估、教育、知情同意和定期监测患者使用阿立哌唑的重要性,这些患者增加了使用药物的冲动或强迫行为,以及其他冲动-强迫行为。需要进一步的研究来证实这种联系。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
4.00
自引率
3.40%
发文量
231
审稿时长
4-8 weeks
期刊介绍: Journal of Clinical Psychopharmacology, a leading publication in psychopharmacology, offers a wide range of articles reporting on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, and psychiatric effects of non-psychiatric drugs. The journal keeps clinician-scientists and trainees up-to-date on the latest clinical developments in psychopharmacologic agents, presenting the extensive coverage needed to keep up with every development in this fast-growing field.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信